Drugs for the treatment of patients with unresectable advanced or recurrent cancer who are refractory or intolerant to standard chemotherapy

摘要

The present invention pertains to a medicine, said medicine comprising propagermanium, for treating an advanced or recurrent cancer patient who is non-responsive or non-tolerant to standard chemotherapy and incurable and unresectable.